Lyophilization involves freeze drying of products. In pharmaceutical industries this process is widely used to increase the self-life of antibiotics, vaccines and protein based drugs. Biopharmaceutical companies are using lyophilization services to keep APIs and drugs sterile. Increasing good manufacturing practices are increasing demand of lyophilization services. The growth of the lyophilization services for biopharmaceuticals market is mainly attributed to factors such as rising demand for lyophilized products, and rapid growth in contract manufacturing and lyophilization services across the world. However, the market is likely to get impacted by the demerits associated with lyophilization process during the forecast period.
LSNE Contract Manufacturing and Albany Molecular Research (AMRI). -Notable Market Players in Lyophilization Services for Biopharmaceuticals Market
Market leaders operating in the market have undertaken various organic growth strategies in the lyophilization services for biopharmaceuticals Market. The lyophilization services for biopharmaceuticals market majorly consists of the players such as ATTWILL Medical Solutions; Axcellerate Pharma LLC.; AB BioTechnologies, Inc.; Berkshire Sterile Manufacturing, Inc.; Emergent BioSolutions; LSNE Contract Manufacturing; Albany Molecular Research (AMRI); Lyophilization Technology, Inc.; Jubilant HollisterStier LLC; Biofortuna Ltd; and Synerlab Group among others. Several in organic approaches, such as mergers & acquisitions and collaboration in the lyophilization services for biopharmaceuticals market, have resulted in the positive growth of the market. Mergers & Acquisitions help the company to strengthen its revenue, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
Below is the list of the growth strategies done by the players operating in the lyophilization services for biopharmaceuticals market:
| Year | News |
| Jun-2020 | Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test |
| Jun-2020 | Vaxart, Inc., clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced today that it signed a Memorandum of Understanding with Attwill Medical Solutions affirming the party’s intention to establish AMS as a resource for lyophilization development and large scale manufacturing including tableting and enteric coating for Vaxart’s oral COVID-19 vaccine. |
| Mar-2020 | Berkshire Sterile Manufacturing, has been contracted to fill some of the first treatments to aid those afflicted with the novel coronavirus. In early March, the company had been contacted by US health officials and other private companies to produce injectable COVID-19 treatments to be used in clinical trials. |
